Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula
Hui Li
Journal of Ethnopharmacology (2019) Vol. 251, pp. 112442-112442
Closed Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Fa-Da Wang, Jing Zhou, En‐Qiang Chen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 49
Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis)
Chunlei Wei, Jing Qiu, Yuyi Wu, et al.
Journal of Ethnopharmacology (2022) Vol. 297, pp. 115550-115550
Closed Access | Times Cited: 40
Astragalus polysaccharide alleviates alcoholic-induced hepatic fibrosis by inhibiting polymerase I and transcript release factor and the TLR4/JNK/NF-κB/MyD88 pathway
Xu Sun, Yongqiu Zheng, Yaqing Tian, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116662-116662
Closed Access | Times Cited: 37
Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management
Yueyue Guan, Guo-hua Tang, Lei Li, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 2, pp. 146-164
Open Access | Times Cited: 13
Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis
Jian Sun, Yan Chen, Tao Wang, et al.
Phytomedicine (2024) Vol. 125, pp. 155337-155337
Closed Access | Times Cited: 12
Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases
Ziwei Zhou, Meijing Li, Zekuan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118506-118506
Closed Access | Times Cited: 8
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma
Hui Li
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 3, pp. 217-233
Closed Access | Times Cited: 59
Salidroside Inhibits CCl4-Induced Liver Fibrosis in Mice by Reducing Activation and Migration of HSC Induced by Liver Sinusoidal Endothelial Cell-Derived Exosomal SphK1
Qiannan Ye, Yang Zhou, Changqing Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43
Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis
Grace Zhou, Yadong Fu, Jiamei Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 327, pp. 118018-118018
Closed Access | Times Cited: 6
Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues
Hua Miao, Xiaqing Wu, Dandan Zhang, et al.
Pharmacological Research (2020) Vol. 163, pp. 105316-105316
Closed Access | Times Cited: 42
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
Shuo Yuan, Qi Wang, Jiao Li, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Traditional Chinese medicine promotes bone regeneration in bone tissue engineering
Zhengrong Gao, Yun‐Zhi Feng, Ya‐Qiong Zhao, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis
Meijie Jiang, Huang Chun-mei, Qiong Wu, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 115965-115965
Closed Access | Times Cited: 22
Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial
Yufeng Xing, Weichao Zhong, Deti Peng, et al.
Pharmacological Research (2023) Vol. 190, pp. 106737-106737
Open Access | Times Cited: 15
Integrated UHPLC-Q-Exactive Orbitrap HRMS and Serum Pharmacochemistry for the Investigation of Anti-hepatic Fibrosis Effect of BaoGanNing Decoction
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review
Yanyun Li, Changying Li, Jia Fan, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 23-34
Open Access
Knowledge, Attitude, and Practice Toward Liver Fibrosis/Cirrhosis and Traditional Chinese Medicine Treatment Among Medical Staff
Aize Xie, Sarisak Soontornchai, Somchai Bovornkitti, et al.
Journal of Evaluation in Clinical Practice (2025) Vol. 31, Iss. 1
Closed Access
Mechanism of Radix Bupleuri and Hedysarum Multijugum Maxim drug pairs on liver fibrosis based on network pharmacology, bioinformatics and molecular dynamics simulation
Li‐Rong Yu, Pan Yu, Yongchang Cao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0318336-e0318336
Open Access
Silicosis: from pathogenesis to therapeutics
Yang Bi-jun, Xiaoman Liu, Cheng Peng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
ErTao decoction alleviates liver fibrosis by suppressing STING-mediated macrophages and NLRP3 inflammasome activation
Hui Jia, Junjie Li, Xiaoting Chen, et al.
Phytomedicine (2025) Vol. 139, pp. 156489-156489
Closed Access
Electron-Shuttling Characteristics of Cassia obtusifolia Seed Extracts and Antiviral Activities of Anthraquinone Compounds Through In Silico Studies
Stephanie Claire M. Tiongson, Bor‐Yann Chen, Kathlia A. De Castro-Cruz, et al.
Processes (2025) Vol. 13, Iss. 2, pp. 458-458
Open Access
Cordycepin attenuates NLRP3/Caspase-1/GSDMD-mediated LPS-induced macrophage pyroptosis
Zige Liu, Lu Li, Wei Jiao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Protective effects of Scutellaria barbata against hepatocyte apoptosis during hepatic fibrosis progression
Feng Li, Bi Wang, Xianxian Fu, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Effects of Different Antiviral Treatments on Liver Inflammation and Fibrosis in Patients With Chronic Hepatitis B
Huiqing Liang, Xiaoting Zheng, Yaoyu Liu, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 4
Closed Access
Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis
Yahang Wang, Yuanyuan Li, Hua Zhang, et al.
Phytomedicine (2021) Vol. 84, pp. 153513-153513
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top